Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2001-5-25
pubmed:abstractText
Although human c-IAP1 and c-IAP2 have been reported to possess antiapoptotic activity against a variety of stimuli in several mammalian cell types, we observed that full-length c-IAP1 and c-IAP2 failed to protect cells from apoptosis induced by Bax overexpression, tumor necrosis factor alpha treatment or Sindbis virus infection. However, deletion of the C-terminal RING domains of c-IAP1 and c-IAP2 restored antiapoptotic activity, indicating that this region negatively regulates the antiapoptotic function of the N-terminal BIR domain. This finding is consistent with the observation by others that the spacer region and RING domain of c-IAP1 functions as an E3 ligase, promoting autoubiquitination and degradation of c-IAP1. In addition, we found that c-IAP1 is cleaved during apoptosis to 52- and 35-kDa fragments. Both fragments contain the C-terminal end of c-IAP1 including the RING finger. In vitro cleavage of c-IAP1 with apoptotic cell extracts or with purified recombinant caspase-3 produced similar fragments. Furthermore, transfection of cells with the spacer-RING domain alone suppressed the antiapoptotic function of the N-terminal BIR domain of c-IAP1 and induced apoptosis. Optimal death-inducing activity of the spacer-RING required both the spacer region and the zinc-binding RING domain of c-IAP1 but did not require the caspase recruitment domain located within the spacer region. To the contrary, deletion of the caspase recruitment domain increased proapoptotic activity, apparently by stabilizing the C-terminal fragment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
9
pubmed:volume
276
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7602-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11106668-Animals, pubmed-meshheading:11106668-Apoptosis, pubmed-meshheading:11106668-Binding Sites, pubmed-meshheading:11106668-CHO Cells, pubmed-meshheading:11106668-Caspase 3, pubmed-meshheading:11106668-Caspases, pubmed-meshheading:11106668-Cell Line, pubmed-meshheading:11106668-Cricetinae, pubmed-meshheading:11106668-Gene Deletion, pubmed-meshheading:11106668-Humans, pubmed-meshheading:11106668-Immunoblotting, pubmed-meshheading:11106668-Inhibitor of Apoptosis Proteins, pubmed-meshheading:11106668-Models, Genetic, pubmed-meshheading:11106668-Mutagenesis, Site-Directed, pubmed-meshheading:11106668-Plasmids, pubmed-meshheading:11106668-Protein Binding, pubmed-meshheading:11106668-Protein Structure, Tertiary, pubmed-meshheading:11106668-Sindbis Virus, pubmed-meshheading:11106668-Transfection, pubmed-meshheading:11106668-Viral Proteins, pubmed-meshheading:11106668-Zinc
pubmed:year
2001
pubmed:articleTitle
c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment.
pubmed:affiliation
Department of Molecular Microbiology and Immunology, Johns Hopkins Schools of Public Health and Medicine, Baltimore, Maryland 21205, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't